Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug - Oligonucleotide Therapeutics Society

Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug

AUTHOR

OTS

DATE

July 5, 2020

CATEGORIES

Delivery,Reviews

SHARE

Post Views: 574

Debacker AJ, Voutila J, Catley M, Blakey D, Habib N.

Mol Ther. 2020 Jun 17:S1525-0016(20)30305-1.

Related articles

Subscribe to our Newsletter

OTS_Logo_retina

Oligonucleotide Therapeutics Society

c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA

(619) 795-9458
info@oligotherapeutics.org

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2022 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Username/Email Address:
Password:
Forgot Password? | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors
By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

Already have an account? Login